Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-02-12T01:46:39.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T23:44:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle, capitalization updates to metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new revision tag v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:41:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed, representing a minor site maintenance update without changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:01:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now includes a Locations section with Michigan, Ohio, and Wisconsin sites and removes the HHS Vulnerability Disclosure entry from the footer.
    Difference
    0.4%
    Check dated 2025-12-23T21:37:11.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.2.0 to v3.3.2, a change to metadata rather than study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:45.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.